Home
KVAC vs CLYM Comparison

KVAC vs CLYM Comparison

Compare KVAC & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KVAC

CLYM

Machine Learning Prediction

ML Decision
KVAC
CLYM

Stock Information

Founded
KVAC 2021
CLYM 2018

Country
KVAC United States
CLYM United States

Employees
KVAC N/A
CLYM N/A

Industry
KVAC
CLYM

Sector
KVAC
CLYM

Exchange
KVAC Nasdaq
CLYM NYSE

Market Cap
KVAC 212.1M
CLYM 201.7M

IPO Year
KVAC 2023
CLYM 2021

Fundamental

Price
KVAC $11.02
CLYM $1.95

Analyst Decision
KVAC
CLYM

Analyst Count
KVAC 0
CLYM 0

Target Price
KVAC N/A
CLYM N/A

AVG Volume (30 Days)
KVAC 16.4K
CLYM 667.9K

Earning Date
KVAC 01-01-0001
CLYM 11-12-2024

Dividend Yield
KVAC N/A
CLYM N/A

EPS Growth
KVAC N/A
CLYM N/A

EPS
KVAC 0.43
CLYM N/A

Revenue
KVAC N/A
CLYM N/A

Revenue This Year
KVAC N/A
CLYM N/A

Revenue Next Year
KVAC N/A
CLYM N/A

P/E Ratio
KVAC $25.54
CLYM N/A

Revenue Growth
KVAC N/A
CLYM N/A

52 Week Low
KVAC $10.37
CLYM $1.73

52 Week High
KVAC $11.02
CLYM $11.55

Technical

Relative Strength Index (RSI)
KVAC 85.22
CLYM N/A

Support Level
KVAC $10.94
CLYM N/A

Resistance Level
KVAC $10.99
CLYM N/A

Average True Range (ATR)
KVAC 0.00
CLYM 0.00

MACD
KVAC -0.00
CLYM 0.00

Stochastic Oscillator
KVAC 100.00
CLYM 0.00

About KVAC Keen Vision Acquisition Corporation

Keen Vision Acquisition Corp is a blank check company.

About CLYM CLIMB BIO INC

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Share on Social Networks: